-
The fine appears small compared to also having to pay $75.37 million to resolve civil allegations related to the false medical claims that were generated due to off label illegally promoted use. The ‘Doctor For A Day Program” is listed as an area where the promotions occurred as well as sales...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-21-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, Claims, Prescriptions, FDA, Marketing, Johnson and Johnson, FBI, legal case, Topamax, billing, off label marketing, epilepsy, Orth-McNeil-Janssen
-
The campaign allows individuals to be anonymous too, and with recent ads on the web and TV this has become a focus. The FDA not only enforces this in the drug and device area but also looks at how foods and other items are marketed and associated advertising from the consumer side of the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-11-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Education, Pharma, FDA, Marketing, Advertising, information, drug reps, DDMAC, promotions
-
This has been the week for Johnson and Johnson, first the recalls and now the FDA questioning the combination of drugs offering relief and helping people fall asleep with getting pain relief from the acetaminophen. This is not the first inquiry with consumer products as last year the FDA called...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-06-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, FDA, Marketing, Advertising, Study, Pain Relief, Novartis, consumer products, reports, Tylenol PM, Excedrin PM
-
In the news of late we have so many studies appearing and conflicts with the experts on which drug to take and for what problem. In this case Avodart may work on on problem; however, the risk of heart failure arises, so what does one do now, prescribe Crestor to handle that part of the issue to...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
04-02-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, FDA, Marketing, Prostate Cancer, Merck, Heart Failure, Statins, GlaxoSmithKline, Studies, Proscar, finasteride, Avodart, Journals, generic drug
-
Is my doctor going to become an FDA approved “Crestor” pusher? We still have conflicts here on which is the right way to go, but now doctors can prescribe Crestor to individuals who have no problems with cholesterol problems. This seems to be some type of daily vaccine of sorts, and AstraZeneca...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
04-01-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Heart Disease, FDA, Marketing, Diabetes, medication, Statins, Sales, Crestor, Jupiter report, cholesterol, AstraZeneca
-
What next, and I do have to say I have never heard of anyone wanting to drink in order to get a sufficient supply of vitamin, as you don’t go to a bar to normally seek out vitamins either. Marketing, marketing, marketing….I would have no idea if this has any effect on the taste but there is a video...
-
It seems any more every package of food you see says something to the effect that “this is good for you” in some fashion or another. You know I’m getting confused here as perhaps some others may be as well, if all the food is so good for all of us, where’s the bad stuff? When you stop and...
-
Stryker has been in the news quite a bit lately and the last post discussed the indictment of some of their top management, but on with today’s news they are buying a company that re-works medical devices, good business to be in today. Stryker Biotech and its Top Management Indicted – Alleged Illegal...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-01-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Surgery, healthcare, Medical Devices, FDA, Marketing, Stryker, bone putty, indictment, Ascent
-
United Healthcare has so many entities in healthcare and here is one more, i3 that is partnering with clinical trial company Acurian to provide business intelligence data mining to work towards increasing participants with clinical trials by mining and identifying the individuals. Ingenix...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-29-2009
Filed under:
Filed under: Medically Related, Technology, Insurance, healthcare, Health IT, Pharma, FDA, clinical trials, HIPAA, Marketing, Business Intelligence, Acurian, United HealthCare, science research, medication records, i3
-
If you liked having vitamin C in your cold and flu medication from Vicks, well it looks like some changes might on on hand here as the FDA states that Vitamin C lacks sufficient data as being effective in preventing or treating a cold. That’s right, you read this correctly, so if you have a cold...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, FDA, Marketing, Advertising, Vitamins, Proctor and Gamble, Nyquil, Dayquil, monograph, consumer products, Vicks
-
Some of the executives could face up to 20 years in prison along with fines, there are a number of management individuals named in the case. Earlier this year we had another company charged with unlawful clinical trials when 3 patients died on the operating table, and one other interesting fact...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-29-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Surgery, healthcare, Medical Devices, FDA, Marketing, Stryker, bone putty, Norian, Calstrux, indictment
-
This is a long video, about an hour so sit down when you have time or do some fast forwarding. What is interesting is that one individuals discusses how the move from the NIH to private pharmaceutical companies took place in the 90s. NIH funds dried up and pharma took over with clinical trials...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-14-2009
Filed under:
Filed under: Technology, Pharma/FDA News, Pharma, FDA, Marketing, Heatlhcare, Side Effects, NIH, Research and Development, medical journals, drug reps, New England Journal of Medicine, ghostwriters, pharmaceutical companies, JAMA
-
In healthcare we all know the name Phillips and this may be a different division promoting the sex toys, vibrators or what ever it is they are now marketing. I did a screenshot of their healthcare page below. Where would these fit in? Any idea or am I maybe on the wrong page, since...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-03-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, healthcare, Medical Devices, Cancer, FDA, Blood Pressure, Marketing, Advertising, Sales, Phillips, consumers, sex toys
-
This appears to have gone one step further in the fact that a program was developed internally with a “how to” structure, and one individual spoke out in dismay with naming it after a “cartoon ghost”. Paxil now has generic competition as well as from other name brand drugs. I wonder how many...
-
I will once more mention a potential change of paradigms here with educating the public. Each patient who took the drug is unique. Do we have any information on other drugs they were taking at the same time? Groups will continue to advise against the use until the full facts are known...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, healthcare, Pharma, PHR, FDA, Marketing, paradigms, personal heatlh records